Target intelligence / Profile preview

Influenza virus hemagglutinin stalk region (HA stalk)

Target
HA stalk
Molecular classification
Viral surface glycoprotein, Class I fusion protein, Antigen
01

Overview

The influenza virus hemagglutinin (HA) stalk region is a highly conserved domain of the HA surface glycoprotein, which is essential for viral entry into host cells (UniProt P03435). Unlike the immunodominant and highly variable globular head, the stalk region—primarily composed of the HA2 subunit and the N- and C-terminal segments of HA1—mediates the fusion of the viral envelope with the endosomal membrane (PubMed: 21852404). This fusion process is triggered by the acidic environment of the endosome, which induces a massive conformational rearrangement in the stalk, transitioning it from a metastable pre-fusion state to a stable post-fusion state (PubMed: 26303263). Because the stalk is relatively conserved across different influenza strains and subtypes, it has become a primary target for the development of universal influenza vaccines and broadly neutralizing antibodies (bnAbs) (Nature: 10.1038/nature10376). Therapeutic agents targeting this region, such as the monoclonal antibodies MEDI8852 and CR9114 or small molecules like JNJ-4796, work by stabilizing the pre-fusion conformation or sterically hindering the structural rearrangements necessary for membrane fusion, thereby preventing the release of the viral genome into the host cytoplasm (Science: 10.1126/science.1224208).

Other names
Hemagglutinin stem regionHA2 subunitConserved HA stalk domainInfluenza HA stalk
02

Mechanism of action

Binding to the conserved HA stalk region to sterically inhibit the pH-induced conformational change required for viral-host membrane fusion, thereby preventing viral entry and genome release (PubMed: 21852404, 22878502).

03

Biological functions

Viral entryMembrane fusionViral attachment
04

Disease associations

InfectionInfluenza
05

Safety considerations

Antibody-dependent enhancement (ADE) (PubMed: 31844282)Vaccine-associated enhanced respiratory disease (VAERD) (PubMed: 24336214)Potential for viral escape mutations in the stalk domain (PubMed: 25501921)
06

Interacting drugs

MEDI8852

7 more in the full profile.

07

Biomarkers

Anti-HA stalk antibody titers (ELISA) (PubMed: 29439166)HA-stalk specific memory B cell frequency (PubMed: 30531979)

Beyond the preview

Go deeper on Influenza virus hemagglutinin stalk region (HA stalk).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza virus hemagglutinin stalk region (HA stalk).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call